| High activity of sorafenib in FLT3-ITD-positive acute myeloid leukemia synergizes with allo-immune effects to induce sustained responses SK Metzelder, T Schroeder, A Finck, S Scholl, M Fey, K Götze, YC Linn, ... Leukemia 26 (11), 2353-2359, 2012 | 260 | 2012 |
| CD16 is indispensable for antibody-dependent cellular cytotoxicity by human monocytes WH Yeap, KL Wong, N Shimasaki, ECY Teo, JKS Quek, HX Yong, ... Scientific reports 6 (1), 34310, 2016 | 259 | 2016 |
| Cytokine-induced killer cells: NK-like T cells with cytotolytic specificity against leukemia YC Linn, KM Hui Leukemia & lymphoma 44 (9), 1457-1462, 2003 | 253 | 2003 |
| A meta-analysis of unrelated donor umbilical cord blood transplantation versus unrelated donor bone marrow transplantation in adult and pediatric patients WYK Hwang, M Samuel, D Tan, LP Koh, W Lim, YC Linn Biology of Blood and Marrow Transplantation 13 (4), 444-453, 2007 | 210 | 2007 |
| Generation of cytokine‐induced killer cells from leukaemic samples with in vitro cytotoxicity against autologous
and allogeneic leukaemic blasts YC Linn, LC Lau, KM Hui British journal of haematology 116 (1), 78-86, 2002 | 185 | 2002 |
| Characterization of the recognition and functional heterogeneity exhibited by cytokine‐induced killer cell subsets against acute myeloid leukaemia target cell YC Linn, SKJ Lau, BH Liu, LH Ng, HX Yong, KM Hui Immunology 126 (3), 423-435, 2009 | 174 | 2009 |
| Expansion of cytotoxic CD3+ CD56+ cells from peripheral blood progenitor cells of patients undergoing autologous hematopoietic cell transplantation JC Alvarnas, YC Linn, EG Hope, RS Negrin Biology of Blood and Marrow Transplantation 7 (4), 216-222, 2001 | 167 | 2001 |
| Developing traditional Chinese medicine in the era of evidence‐based medicine: current evidences and challenges FY Fung, YC Linn Evidence‐Based Complementary and Alternative Medicine 2015 (1), 425037, 2015 | 166 | 2015 |
| Cytokine‐induced NK‐like T cells: from bench to bedside YC Linn, KM Hui BioMed Research International 2010 (1), 435745, 2010 | 115 | 2010 |
| The anti-tumour activity of allogeneic cytokine-induced killer cells in patients who relapse after allogeneic transplant for haematological malignancies YC Linn, M Niam, S Chu, A Choong, HX Yong, KK Heng, W Hwang, Y Loh, ... Bone marrow transplantation 47 (7), 957-966, 2012 | 105 | 2012 |
| Comparative gene expression profiling of cytokine-induced killer cells in response to acute myloid leukemic and acute lymphoblastic leukemic stimulators using oligonucleotide … YC Linn, SM Wang, KM Hui Experimental hematology 33 (6), 671-681, 2005 | 75 | 2005 |
| A phase I/II clinical trial of autologous cytokine-induced killer cells as adjuvant immunotherapy for acute and chronic myeloid leukemia in clinical remission YC Linn, HX Yong, M Niam, TJ Lim, S Chu, A Choong, C Chuah, YT Goh, ... Cytotherapy 14 (7), 851-859, 2012 | 72 | 2012 |
| Immune checkpoint inhibitors enhance cytotoxicity of cytokine-induced killer cells against human myeloid leukaemic blasts SL Poh, YC Linn Cancer Immunology, Immunotherapy 65, 525-536, 2016 | 65 | 2016 |
| Natural killer cells for therapy of leukemia G Suck, YC Linn, T Tonn Transfusion Medicine and Hemotherapy 43 (2), 89-95, 2016 | 57 | 2016 |
| Clinical scale expansion of cytokine-induced killer cells is feasible from healthy donors and patients with acute and chronic myeloid leukemia at various stages of therapy M Niam, YC Linn, SF Chong, TJ Lim, S Chu, A Choong, HX Yong, G Suck, ... Experimental Hematology 39 (9), 897-903. e1, 2011 | 57 | 2011 |
| Fludarabine in comparison to alkylator-based regimen as induction therapy for chronic lymphocytic leukemia: a systematic review and meta-analysis Q Zhu, DCL Tan, M Samuel, ESY Chan, YC Linn Leukemia & lymphoma 45 (11), 2239-2245, 2004 | 54 | 2004 |
| Berberine‐induced Haemolysis Revisited: Safety of Rhizoma coptidis and Cortex phellodendri in Chronic Haematological Diseases Y Linn, J Lu, L Lim, H Sun, J Sun, Y Zhou, H Ng Phytotherapy Research 26 (5), 682-686, 2012 | 52 | 2012 |
| Successful treatment of primary granulocytic sarcoma by non-myeloablative stem cell transplant D Tan, GC Wong, LP Koh, W Hwang, Y Loh, YC Linn, YT Goh Leukemia & lymphoma 47 (1), 159-162, 2006 | 52 | 2006 |
| Risk of hepatitis B reactivation and the role of novel agents and stem-cell transplantation in multiple myeloma patients with hepatitis B virus (HBV) infection DHT Mya, ST Han, YC Linn, WYK Hwang, YT Goh, DCL Tan Annals of oncology 23 (2), 421-426, 2012 | 51 | 2012 |
| Interleukin-15 supports generation of highly potent clinical-grade natural killer cells in long-term cultures for targeting hematological malignancies G Suck, VYS Oei, YC Linn, SH Ho, S Chu, A Choong, M Niam, MBC Koh Experimental Hematology 39 (9), 904-914, 2011 | 50 | 2011 |
